Jupiter Life Line Hospitals Share Price
271.40+8.50 (+3.23%)
-13.53% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
APOLLOHOSPNSE
MAXHEALTHNSE
MANIPALHOSNSE
ASTERDMNSE
FORTISNSE
NHNSE
MEDANTANSE
LALPATHLABNSE
KIMSNSE
AGARWALEYENSE
JLHLNSE
Jupiter Life Line Hospitals Share Price
271.40+8.50 (+3.23%)
-13.53% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | 25% | 19% | 15% |
| - | - | 39% | 0% |
| - | - | 9% | -16% |
| 15% | 19% | 17% | 13% |
Peer Comparison
Symbol
APOLLOHOSP
MAXHEALTH
MANIPALHOS
ASTERDM
FORTIS
NH
MEDANTA
LALPATHLAB
KIMS
AGARWALEYE
JLHL
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 8,523 | ₹121412 Cr | 58.11 | 40.39 | 207.67 | ₹1942 Cr |
| 918.2 | ₹87015 Cr | 63.03 | 4.26 | 19.36 | ₹1442 Cr |
| 666.3 | ₹84796 Cr | 95.03 | 1.96 | 11.95 | ₹892 Cr |
| 700 | ₹59431 Cr | 186.49 | 0.31 | 6.76 | ₹388 Cr |
| 785.85 | ₹59227 Cr | 56.52 | 3.53 | 20.1 | ₹1042 Cr |
| 1,922.6 | ₹38205 Cr | 44.49 | 14.73 | 71.14 | ₹806 Cr |
| 1,392.5 | ₹35671 Cr | 57.68 | 8.21 | 32.95 | ₹556 Cr |
| 1,915.3 | ₹32373 Cr | 59.74 | 10.11 | 42.51 | ₹505 Cr |
| 735.15 | ₹30682 Cr | 150.18 | 1.04 | 12.74 | ₹241 Cr |
| 518.05 | ₹16250 Cr | 109.52 | 1.43 | 13.88 | ₹133 Cr |
| 276.3 | ₹8633 Cr | 46.31 | 1.71 | 8.73 | ₹194 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹456 Cr | ₹411 Cr | ₹388 Cr | ₹365 Cr | ₹394 Cr | ₹353 Cr | ₹327 Cr | ₹321 Cr | ₹323 Cr | ₹289 Cr | ₹291 Cr | ₹273 Cr | ₹263 Cr | ₹243 Cr | ₹242 Cr | ₹228 Cr | ₹221 Cr | ₹201 Cr |
| ₹11 Cr | ₹11 Cr | ₹9 Cr | ₹9 Cr | ₹11 Cr | ₹13 Cr | ₹7 Cr | ₹8 Cr | ₹9 Cr | ₹7 Cr | ₹8 Cr | ₹8 Cr | ₹4 Cr | ₹5 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr |
| ₹467 Cr | ₹422 Cr | ₹397 Cr | ₹374 Cr | ₹405 Cr | ₹366 Cr | ₹334 Cr | ₹329 Cr | ₹332 Cr | ₹295 Cr | ₹299 Cr | ₹281 Cr | ₹267 Cr | ₹248 Cr | ₹246 Cr | ₹231 Cr | ₹224 Cr | ₹203 Cr |
| ₹378 Cr | ₹358 Cr | ₹322 Cr | ₹304 Cr | ₹323 Cr | ₹296 Cr | ₹266 Cr | ₹260 Cr | ₹262 Cr | ₹234 Cr | ₹239 Cr | ₹221 Cr | ₹213 Cr | ₹201 Cr | ₹201 Cr | ₹193 Cr | ₹176 Cr | ₹161 Cr |
| ₹117 Cr | ₹90 Cr | ₹98 Cr | ₹93 Cr | ₹104 Cr | ₹91 Cr | ₹85 Cr | ₹83 Cr | ₹84 Cr | ₹72 Cr | ₹71 Cr | ₹70 Cr | ₹65 Cr | ₹58 Cr | ₹55 Cr | ₹48 Cr | ₹58 Cr | ₹51 Cr |
| ₹14 Cr | ₹13 Cr | ₹9 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹6 Cr | ₹3 Cr | ₹1 Cr | ₹1 Cr | ₹93 L | ₹1 Cr | ₹12 Cr | ₹12 Cr | ₹11 Cr | ₹11 Cr | ₹10 Cr | ₹10 Cr |
| ₹75 Cr | ₹51 Cr | ₹68 Cr | ₹57 Cr | ₹74 Cr | ₹62 Cr | ₹62 Cr | ₹67 Cr | ₹69 Cr | ₹60 Cr | ₹62 Cr | ₹58 Cr | ₹41 Cr | ₹34 Cr | ₹32 Cr | ₹27 Cr | ₹38 Cr | ₹32 Cr |
| ₹56 Cr | ₹38 Cr | ₹50 Cr | ₹42 Cr | ₹57 Cr | ₹44 Cr | ₹45 Cr | ₹53 Cr | ₹52 Cr | ₹45 Cr | ₹45 Cr | ₹44 Cr | ₹34 Cr | ₹54 Cr | ₹16 Cr | -₹38 L | ₹27 Cr | ₹30 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — |
| ₹66 Cr | ₹66 Cr | ₹66 Cr | ₹57 Cr | ₹51 Cr | ₹51 Cr | ₹51 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹2 Cr | ₹0 | ₹0 |
| ₹1479 Cr | ₹1291 Cr | ₹1103 Cr | ₹309 Cr | ₹241 Cr | ₹188 Cr | ₹186 Cr |
| ₹1479 Cr | ₹1291 Cr | ₹1103 Cr | ₹309 Cr | ₹241 Cr | ₹188 Cr | ₹186 Cr |
| ₹1544 Cr | ₹1356 Cr | ₹1169 Cr | ₹366 Cr | ₹294 Cr | ₹239 Cr | ₹237 Cr |
| ₹90,000 | ₹6 L | -₹30 L | -₹2 Cr | -₹5 Cr | ₹7 Cr | ₹0 |
| ₹501 Cr | ₹322 Cr | ₹0 | ₹453 Cr | ₹463 Cr | ₹418 Cr | ₹244 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹1 Cr | ₹3 Cr | ₹0 |
| ₹10 Cr | ₹7 Cr | ₹4 Cr | ₹37 Cr | ₹33 Cr | ₹25 Cr | ₹20 Cr |
| ₹66 Cr | ₹62 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹16 Cr | ₹11 Cr | ₹3 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹593 Cr | ₹402 Cr | ₹7 Cr | ₹489 Cr | ₹497 Cr | ₹447 Cr | ₹263 Cr |
| — | — | — | — | — | — | — |
| ₹96 Cr | ₹69 Cr | ₹62 Cr | ₹71 Cr | ₹61 Cr | ₹59 Cr | ₹59 Cr |
| ₹118 Cr | ₹83 Cr | ₹23 Cr | ₹29 Cr | ₹19 Cr | ₹22 Cr | ₹12 Cr |
| ₹0 | ₹71 L | ₹0 | ₹5 Cr | ₹23 Cr | -₹8 Cr | ₹20 Cr |
| ₹13 Cr | ₹6 Cr | ₹21 Cr | ₹27 Cr | ₹20 Cr | ₹23 Cr | ₹13 Cr |
| ₹227 Cr | ₹158 Cr | ₹106 Cr | ₹132 Cr | ₹123 Cr | ₹96 Cr | ₹103 Cr |
| ₹2363 Cr | ₹1917 Cr | ₹1281 Cr | ₹986 Cr | ₹909 Cr | ₹789 Cr | ₹603 Cr |
| ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹1 Cr | ₹1 Cr | ₹43 L |
| ₹509 Cr | ₹326 Cr | ₹0 | ₹469 Cr | ₹495 Cr | ₹426 Cr | ₹272 Cr |
| — | — | — | — | — | — | — |
| ₹1781 Cr | ₹1290 Cr | ₹1005 Cr | ₹965 Cr | ₹891 Cr | ₹802 Cr | ₹576 Cr |
| ₹397 Cr | ₹312 Cr | ₹288 Cr | ₹245 Cr | ₹207 Cr | ₹172 Cr | ₹141 Cr |
| ₹1384 Cr | ₹978 Cr | ₹718 Cr | ₹720 Cr | ₹684 Cr | ₹630 Cr | ₹435 Cr |
| ₹129 Cr | ₹185 Cr | ₹74 Cr | ₹29 Cr | ₹27 Cr | ₹26 Cr | ₹11 Cr |
| ₹10 L | ₹12 L | ₹14 L | ₹15 L | ₹15 L | ₹15 L | ₹13 L |
| ₹10 L | ₹12 L | ₹14 L | ₹15 L | ₹15 L | ₹15 L | ₹13 L |
| ₹155 Cr | ₹55 Cr | ₹58 Cr | ₹7 Cr | ₹11 Cr | ₹16 Cr | ₹24 Cr |
| ₹10 Cr | ₹7 Cr | ₹22 Cr | ₹21 Cr | ₹7 Cr | ₹4 Cr | ₹0 |
| ₹1678 Cr | ₹1225 Cr | ₹872 Cr | ₹776 Cr | ₹728 Cr | ₹676 Cr | ₹469 Cr |
| — | — | — | — | — | — | — |
| ₹486 Cr | ₹507 Cr | ₹17 Cr | ₹1 Cr | ₹3 Cr | ₹7 Cr | ₹2 Cr |
| ₹38 Cr | ₹26 Cr | ₹21 Cr | ₹19 Cr | ₹15 Cr | ₹13 Cr | ₹14 Cr |
| ₹76 Cr | ₹43 Cr | ₹57 Cr | ₹46 Cr | ₹28 Cr | ₹22 Cr | ₹45 Cr |
| ₹58 Cr | ₹95 Cr | ₹301 Cr | ₹134 Cr | ₹103 Cr | ₹19 Cr | ₹7 Cr |
| ₹18 Cr | ₹13 Cr | ₹6 Cr | ₹5 Cr | ₹3 Cr | ₹4 Cr | ₹6 Cr |
| ₹9 Cr | ₹7 Cr | ₹7 Cr | ₹4 Cr | ₹28 Cr | ₹47 Cr | ₹59 Cr |
| ₹685 Cr | ₹693 Cr | ₹410 Cr | ₹209 Cr | ₹180 Cr | ₹113 Cr | ₹134 Cr |
| ₹458 Cr | ₹534 Cr | ₹304 Cr | ₹77 Cr | ₹57 Cr | ₹17 Cr | ₹31 Cr |
| ₹2363 Cr | ₹1917 Cr | ₹1281 Cr | ₹986 Cr | ₹909 Cr | ₹789 Cr | ₹603 Cr |
| ₹236 | ₹207 | ₹178 | ₹65 | ₹57 | ₹47 | ₹47 |
| ₹236 | ₹207 | ₹178 | ₹65 | ₹57 | ₹47 | ₹47 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
| ₹265 Cr | ₹261 Cr | ₹195 Cr | ₹129 Cr | ₹77 Cr | ₹2 Cr | ₹33 Cr |
| ₹88 Cr | ₹49 Cr | ₹50 Cr | ₹76 Cr | ₹77 Cr | ₹68 Cr | ₹66 Cr |
| -₹21 Cr | ₹21 Cr | -₹81 Cr | -₹54 Cr | -₹9 Cr | ₹63 Cr | -₹9 Cr |
| ₹332 Cr | ₹331 Cr | ₹164 Cr | ₹150 Cr | ₹146 Cr | ₹133 Cr | ₹89 Cr |
| ₹268 Cr | ₹267 Cr | ₹115 Cr | ₹117 Cr | ₹137 Cr | ₹123 Cr | ₹74 Cr |
| -₹442 Cr | -₹497 Cr | -₹246 Cr | -₹104 Cr | -₹85 Cr | -₹296 Cr | -₹43 Cr |
| ₹136 Cr | ₹297 Cr | ₹128 Cr | ₹18 Cr | ₹33 Cr | ₹185 Cr | -₹32 Cr |
| -₹38 Cr | ₹66 Cr | -₹3 Cr | ₹31 Cr | ₹85 Cr | ₹12 Cr | -₹92 L |
| ₹93 Cr | ₹26 Cr | ₹26 Cr | ₹103 Cr | ₹18 Cr | ₹7 Cr | ₹8 Cr |
| ₹55 Cr | ₹93 Cr | ₹23 Cr | ₹134 Cr | ₹103 Cr | ₹19 Cr | ₹7 Cr |
Fundamental Ratios
Consolidated
Standalone
No results found
Jupiter Life Line Hospitals Share Price
271.40+8.50 (+3.23%)
-13.53% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 4
Bearish signals: 5 out of 9 oscillators
RSI
61.75Buy
STOCH %K
95.96Sell
MACD Level(12,26)
-0.74Sell
Ultimate Oscillator
57.15Buy
Aroon Oscillator
-84.00Sell
BOP
0.82Buy
CCI
171.27Sell
Williams %R
-4.04Sell
Momentum
29.40Buy
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 8
Bearish signals: 1 out of 9 moving averages
EMA 9
259.86Buy
SMA 9
258.33Buy
EMA 21
257.77Buy
SMA 21
251.94Buy
EMA 50
266.78Buy
SMA 50
268.61Buy
EMA 200
276.68Sell
SMA 200
270.46Buy
WMA 20
254.93Buy
Pivot
Pivot
Classic
Resistance 5
289.33
Resistance 4
282.93
Resistance 3
276.53
Resistance 2
270.13
Resistance 1
266.52
Pivot
263.73
Support 1
260.12
Support 2
257.33
Support 3
250.93
Support 4
244.53
Support 5
238.13
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Jupiter Life Line Hospitals Share Price
271.40+8.50 (+3.23%)
-13.53% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| 40.91% | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% |
| 9.13% | 9.37% | 8.48% | 8.48% | 9.06% | 9.77% |
| 2.26% | 2.20% | 2.62% | 2.47% | 2.56% | 1.35% |
| 13.45% | 10.89% | 10.97% | 11.55% | 10.99% | 11.05% |
| 34.25% | 36.63% | 37.02% | 36.59% | 36.48% | 36.92% |
Bulk & block deals
Name
Think India Opportunities Master Fund Lp
Raghavan Vadapatra Sayee
Brindha Raghavan
Tibrewala Ramakant Sushma
Elixir Wealth Management Private Limited
Elixir Wealth Management Private Limited
Nk Securities Research Private Limited
Graviton Research Capital Llp
Graviton Research Capital Llp
Nk Securities Research Private Limited
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 29 Aug 2024 | Purchase | 26.20 Cr | ₹1,310 | 2 L | Block | 0.061007 | NSE |
| 29 Aug 2024 | Sell | 13.10 Cr | ₹1,310 | 1 L | Block | 0.030504 | NSE |
| 29 Aug 2024 | Sell | 13.10 Cr | ₹1,310 | 1 L | Block | 0.030504 | NSE |
| 21 Jun 2024 | Sell | 50.04 Cr | ₹1,200.03 | 4.17 L | Bulk | 0.1272 | NSE |
| 18 Sep 2023 | Purchase | 36.67 Cr | ₹1,051.90 | 3.49 L | Bulk | 0.106344 | NSE |
| 18 Sep 2023 | Sell | 36.30 Cr | ₹1,049.40 | 3.46 L | Bulk | 0.105505 | NSE |
| 18 Sep 2023 | Sell | 64.52 Cr | ₹1,040.65 | 6.20 L | Bulk | 0.189125 | NSE |
| 18 Sep 2023 | Sell | 38.09 Cr | ₹1,049.88 | 3.63 L | Bulk | 0.110659 | NSE |
| 18 Sep 2023 | Purchase | 38.06 Cr | ₹1,049.01 | 3.63 L | Bulk | 0.110659 | NSE |
| 18 Sep 2023 | Purchase | 64.49 Cr | ₹1,040.07 | 6.20 L | Bulk | 0.189125 | NSE |
Insider trading & SAST
Client name
Sbi Mutual Funds
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 Sep 2023 | — | Acquisition | 6.04 | 7.48 | 0 | — | 39.65 L | 18 Sep 2023 | Market | 49,07,057 | SAST | 29(1) | — |
Jupiter Life Line Hospitals Share Price
271.40+8.50 (+3.23%)
-13.53% past 1 Year
Jupiter Life Line Hospitals Limited is engaged in the business of operating and managing hospitals and clinics in India. The company is among the key multi-specialty tertiary and quaternary healthcare
Corporate Actions
Date
Type
Details
Company details
Jupiter Life Line Hospitals Share Price
271.40+8.50 (+3.23%)
-13.53% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Jupiter Life Line Hospitals Share Price
271.40+8.50 (+3.23%)
-13.53% past 1 Year
News
JLHL Reports Higher Q2 EBITDA With Stable Operating Margin
Equity
JLHL
Jupiter Life Line Hospitals Reports Slight Q2 Profit Decline
Equity
JLHL
Jupiter Life Line Hospitals Reports Strong Second Quarter Revenue Growth
Equity
JLHL
Jupiter Life Line Hospitals to host analyst and investor meet on September 28
Equity
JLHL
Jupiter Life Line Hospitals unit acquires 100 percent stake in Sulcus Private
Equity
JLHL
Jupiter Life Line Hospitals appoints new Chief Financial Officer Harshad Purani
Equity
JLHL
Jupiter Life Line Hospitals Q1 EBITDA edges up but margin contracts sharply YoY
Equity
JLHL
Jupiter Life Line Hospitals reports Q1 revenue rises to Rs 410 crores
Equity
JLHL
Jupiter Life Line Hospitals reports weaker Q1 profit on year-on-year basis
Equity
JLHL
Jupiter Life Line Hospitals schedules Q1 earnings call for August 3
Equity
JLHL
Jupiter Life Line Hospitals Q4 EBITDA rises year-on-year, margin slightly softens
Equity
JLHL
Jupiter Life Line Hospitals Q4 profit and revenue rise strongly on YoY basis
Equity
JLHL
Jupiter Life Line reports Profit after tax of 49.20 Crores, in the March 2026 quarter
Equity
JLHL
Jupiter Life Line Hospitals Secures MMRDA Approval for 80-Year Land Lease Valued at Rs 354 Crores.
Equity
JLHL
Nuvama Maintains Buy on Jupiter Life Line Hospitals with Rs 1,475 Target Price.
Equity
JLHL
Jupiter Life Line Hospitals informs about press release
Equity
JLHL
Jupiter Life Line - Quaterly Results
Equity
JLHL
Jupiter Life Line Hospitals Q3 EBITDA Rises 9.4% YoY to Rs 83.50 Crores with Stable Margin.
Equity
JLHL
Jupiter Life Line Hospitals Q3FY26 Net Profit Declines 18% YoY to Rs 42.60 Crores, Revenue Up 10% to Rs 365 Crores.
Equity
JLHL
Jupiter Life Line reports Profit after tax of 44.28 Crores, in the December 2025 quarter
Equity
JLHL